Spyre Therapeutics (SYRE) Other Non-Current Liabilities (2015 - 2026)
Spyre Therapeutics (SYRE) reported Other Non-Current Liabilities of $38.62 million for Q2 2026, down 32.2% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, Spyre Therapeutics posted Other Non-Current Liabilities of $26.68 million, down 56.8% from FY2024.
- Other Non-Current Liabilities has a five-year compound annual growth rate of 162.5% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $61.7 million in FY2024 (+49.4%), $41.31 million in FY2023 and $16,000 in FY2021 (-92.5%).
- Five-year quarterly Other Non-Current Liabilities spans a low of $8,000 in Q1 2022 and a high of $61.7 million in Q4 2024.
- Year over year, Other Non-Current Liabilities gained in three of the last six quarters, with growth averaging 27.3%.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q1 2026 (growth of 245.4%); the low point was Q1 2022 (a decline of 96.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $56.95 million (Q1 2026), $26.68 million (Q4 2025) and $3.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Spyre Therapeutics | 7.84 Bn | 7.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.62 Mn |
| Mar 31, 2026 | 56.95 Mn |
| Dec 31, 2025 | 26.68 Mn |
| Sep 30, 2025 | 3.23 Mn |
| Mar 31, 2025 | 16.49 Mn |
| Dec 31, 2024 | 61.70 Mn |
| Sep 30, 2024 | 36.16 Mn |
| Jun 30, 2024 | 39.56 Mn |
| Mar 31, 2024 | 39.11 Mn |
| Dec 31, 2023 | 41.31 Mn |
| Sep 30, 2023 | 20.69 Mn |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | 192,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 206,000.00 |
| Dec 31, 2020 | 214,000.00 |
| Sep 30, 2020 | 61,000.00 |
| Jun 30, 2020 | 68,000.00 |
| Mar 31, 2020 | 23,000.00 |
API Access
Spyre Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();